Wuhan Aoke Botai Biotechnology Co., Ltd., formerly founded in 2002, is a high-tech company specializing in the R & D, production and sales of in vitro diagnostic raw materials (including antigens and antibodies). At the same time, it is a high-tech company that provides customized services for all kinds of monoclonal antibodies, multi-antibodies and recombinant proteins. After decades of development, Our company has passed 15013485 and 1509001 certification, and has won honors such as Optical Valley Gazelle, 3551 talents, provincial innovative small and medium-sized enterprises and provincial "specialized special new" small and medium-sized enterprises. After years of painstaking research and development, the company has created two major technology platforms that are widely praised in the industry, namely, mouse monoclonal antibody hybrid pain platform and recombinant protein expression platform. The mouse hybridoma platform is a leader in the industry, and we are the first company in China to use a pair of monoclonal antibodies to detect hepatitis B HBeAg. The recombinant protein platforms are E. coli expression platform, Pichia pastoris expression platform, insect cell-baculovirus expression system and mammalian cell expression platform. At the same time, the company also has 8000 square meters of animal feeding base, which can fully meet the supply needs of diagnostic reagent manufacturers.